CHICAGO, Ill. (Reuters) — Delays in Chinese approvals of imported genetically modified crops have cut American gross domestic product by about US$7 billion over the past five years by reducing sales of crops and other goods, an industry group that represents global seed companies said May 30.
The report by CropLife International indicates what is at stake for the administration of United States President Donald Trump as it seeks better market access for U.S. GM crops into China as part of a trade deal under discussion.
The U.S. said May 29 it still held its threat of imposing tariffs on $50 billion of imports from China and would use it unless Beijing addressed its concerns over the theft of American intellectual property.
Read Also
Farming Smarter receives financial boost from Alberta government for potato research
Farming Smarter near Lethbridge got a boost to its research equipment, thanks to the Alberta government’s increase in funding for research associations.
Global seeds and chemical companies have long wanted wider access for GM crops in China because it is the world’s top buyer of soybeans and a major buyer of other grains.
China does not permit planting of GM food crops but allows imports of GM soybeans and corn for use in its massive animal feed industry. But the approval process for new GMO strains is slow, unpredictable and not based on science, according to the U.S. biotech industry.
The sector says delays in Chinese approvals hurt the value of U.S. corn harvests by preventing farmers from using new seeds that can protect crops from pests and weeds.
As a result, farmers spend less on products ranging from fertilizer to equipment, with ripple effects on economic growth, said Scott Richman, senior vice-president at Informa Agribusiness Consulting Group, which CropLife commissioned to do the study.
China’s Ministry of Agriculture and Rural Affairs, which regulates GM crop approvals, did not respond to a fax seeking comment on how its approval reviews affect the U.S. economy.
“We need a system in China that facilitates trade,” said Matt O’Mara, a vice-president for the Biotechnology Innovation Organization, a CropLife affiliate.
Companies such as Bayer, Monsanto, DowDuPont and ChemChina’s Syngenta have been waiting as long as seven years for China to approve strains of soybeans, canola and alfalfa.
